Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 241

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

Open access
van de Beek, Diederik, Farrar, Jeremy J, de Gans, Jan, Mai, Nguyen Thi Hoang, Molyneux, Elizabeth M, Peltola, Heikki, Peto, Tim E, Roine, Irmeli, Scarborough, Mathew, Schultsz, Constance, Thwaites, Guy E, Tuan, Phung Quoc, Zwinderman, AH·2010·The Lancet Neurology

Abstract

BACKGROUND: Dexamethasone improves outcome for some patients with bacterial meningitis, but not others. We aimed to identify which patients are most likely to benefit from dexamethasone treatment. METHODS: We did a meta-analysis of individual patient data from the randomised, double-blind, placebo-controlled trials of dexamethasone for bacterial meningitis in patients of all ages for which raw data were available. The pre-determined outcome measures were death at the time of first follow-up, death or severe neurological sequelae at 1 month follow-up, death or any neurological sequelae at first follow-up, and death or severe bilateral hearing loss at first follow-up. Combined odds ratios (ORs) and tests for heterogeneity were calculated using conventional Mantel-Haenszel statistics. We also did exploratory analysis of hearing loss among survivors and other exploratory subgroup analyses by use of logistic regression. FINDINGS: Data from 2029 patients from five trials were included in the analysis (833 [41.0%] aged <15 years). HIV infection was confirmed or likely in 580 (28.6%) patients and bacterial meningitis was confirmed in 1639 (80.8%). Dexamethasone was not associated with a significant reduction in death (270 of 1019 [26.5%] on dexamethasone vs 275 of 1010 [27.2%] on placebo; OR 0.97, 95% CI 0.79-1.19), death or severe neurological sequelae or bilateral severe deafness (42.3%vs 44.3%; 0.92, 0.76-1.11), death or any neurological sequelae or any hearing loss (54.2%vs 57.4%; 0.89, 0.74-1.07), or death or severe bilateral hearing loss (36.4%vs 38.9%; 0.89, 0.73-1.69). However, dexamethasone seemed to reduce hearing loss among survivors (24.1%vs 29.5%; 0.77, 0.60-0.99, p=0.04). Dexamethasone had no effect in any of the prespecified subgroups, including specific causative organisms, pre-dexamethasone antibiotic treatment, HIV status, or age. Pooling of the mortality data with those of all other published trials did not significantly change the results. INTERPRETATION: Adjunctive dexamethasone in the treatment of acute bacterial meningitis does not seem to significantly reduce death or neurological disability. There were no significant treatment effects in any of the prespecified subgroups. The benefit of adjunctive dexamethasone for all or any subgroup of patients with bacterial meningitis thus remains unproven. FUNDING: Wellcome Trust UK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(10)70023-5

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 36

  1. van de Beek, 2006, Community-acquired bacterial meningitis in adults, N Engl J Med, 354, 44, 10.1056/NEJMra052116 · DOI · Paper page
  2. Saez-Llorens, 2003, Bacterial meningitis in children, Lancet, 361, 2139, 10.1016/S0140-6736(03)13693-8 · DOI · Paper page
  3. Scarborough, 2008, The diagnosis and management of acute bacterial meningitis in resource-poor settings, Lancet Neurol, 7, 637, 10.1016/S1474-4422(08)70139-X · DOI
  4. Scheld, 1980, Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis: alterations with penicillin and methylprednisolone, J Clin Invest, 66, 243, 10.1172/JCI109850 · DOI · Paper page
  5. Tauber, 1985, Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis, J Infect Dis, 151, 528, 10.1093/infdis/151.3.528 · DOI · Paper page
  6. van de Beek, 2006, Drug insight: adjunctive therapies in adults with bacterial meningitis, Nat Clin Pract Neurol, 2, 504, 10.1038/ncpneuro0265 · DOI
  7. van de Beek, 2007, Corticosteroids for acute bacterial meningitis, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD004405.pub2 · DOI
  8. Havens, 1989, Corticosteroids as adjunctive therapy in bacterial meningitis: a meta-analysis of clinical trials, Am J Dis Child, 143, 1051, 10.1001/archpedi.1989.02150210085023 · DOI
  9. McIntyre, 1997, Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988, JAMA, 278, 925, 10.1001/jama.278.11.925 · doi:10.1001/jama.278.11.925 · Paper page
  10. van de Beek, 2004, Steroids in adults with acute bacterial meningitis: a systematic review, Lancet Infect Dis, 4, 139, 10.1016/S1473-3099(04)00937-5 · DOI · Paper page
  11. Peltola, 2007, Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 45, 1277, 10.1086/522534 · DOI · Paper page
  12. Nguyen, 2007, Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis, N Engl J Med, 357, 2431, 10.1056/NEJMoa070852 · DOI · Paper page
  13. Scarborough, 2007, Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa, N Engl J Med, 357, 2441, 10.1056/NEJMoa065711 · DOI · Paper page
  14. Molyneux, 2002, Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial, Lancet, 360, 211, 10.1016/S0140-6736(02)09458-8 · DOI · Paper page
  15. de Gans, 2002, Dexamethasone in adults with bacterial meningitis, N Engl J Med, 347, 1549, 10.1056/NEJMoa021334 · DOI · Paper page
  16. Belsey, 1969, Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results, Pediatrics, 44, 503, 10.1542/peds.44.4.503 · DOI
  17. Bademosi, 1979, Prednisolone in the treatment of pneumococcal meningitis, Trop Geograph Med, 31, 53
  18. Bhaumik, 1998, Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults, Neurol India, 46, 225
  19. Ciana, 1995, Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis, J Trop Pediatr, 41, 164, 10.1093/tropej/41.3.164 · DOI
  20. deLemos, 1969, Corticosteroids as an adjunct to treatment in bacterial meningitis: a controlled clinical trial, Pediatrics, 44, 30, 10.1542/peds.44.1.30 · DOI
  21. Girgis, 1989, Dexamethasone treatment for bacterial meningitis in children and adults, Pediatr Infect Dis J, 8, 848, 10.1097/00006454-198912000-00004 · DOI · Paper page
  22. Kanra, 1995, Beneficial effects of dexamethasone in children with pneumococcal meningitis, Pediatr Infect Dis J, 14, 490, 10.1097/00006454-199506000-00005 · DOI
  23. Lebel, 1988, Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials, N Engl J Med, 319, 964, 10.1056/NEJM198810133191502 · DOI · Paper page
  24. Odio, 1991, The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis, N Engl J Med, 324, 1525, 10.1056/NEJM199105303242201 · DOI · Paper page
  25. Qazi, 1996, Dexamethasone and bacterial meningitis in Pakistan, Arch Dis Child, 75, 482, 10.1136/adc.75.6.482 · DOI
  26. Thomas, 1999, Trial of dexamethasone treatment for severe bacterial meningitis in adults: adult Meningitis Steroid Group, Intensive Care Med, 25, 475, 10.1007/s001340050883 · DOI
  27. 1988, United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results, BMJ, 296, 316, 10.1136/bmj.296.6618.316 · DOI · Paper page
  28. Bennett, 1963, The effectiveness of hydrocortisone in the management of severe infections, JAMA, 183, 462, 10.1001/jama.1963.63700060029012 · DOI
  29. King, 1994, Dexamethasone therapy for bacterial meningitis: better never than late?, Can J Infect Dis, 5, 210, 10.1155/1994/257198 · DOI
  30. Lebel, 1989, Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis, Am J Dis Child, 143, 301
  31. Wald, 1995, Dexamethasone therapy for children with bacterial meningitis, Pediatrics, 95, 21, 10.1542/peds.95.1.21 · DOI · Paper page
  32. Kilpi, 1995, Oral glycerol and intravenous dexamethasone in preventing neurologic and audiological sequelae of childhood bacterial-meningitis, Pediatr Infect Dis J, 14, 270, 10.1097/00006454-199504000-00005 · DOI
  33. Schaad, 1993, Dexamethasone therapy for bacterial meningitis in children, Lancet, 342, 457, 10.1016/0140-6736(93)91592-A · DOI · Paper page
  34. van de Beek, 2006, Dexamethasone in adults with community-acquired bacterial meningitis, Drugs, 66, 415, 10.2165/00003495-200666040-00002 · DOI
  35. Fitch, 2008, Drug insight: steroids in CNS infectious diseases—new indications for an old therapy, Nat Clin Pract Neurol, 4, 97, 10.1038/ncpneuro0713 · DOI
  36. Greenwood, 2007, Corticosteroids for acute bacterial meningitis, N Engl J Med, 357, 2507, 10.1056/NEJMe0707474 · doi:10.1056/nejme0707474

Cited by

See all 241

Metadata

Authors
van de Beek, D., Farrar, J. J., de Gans, J., Mai, N. T. H., Molyneux, E. M., Peltola, H., Peto, T. E., Roine, I., Scarborough, M., Schultsz, C., Thwaites, G. E., Tuan, P. Q., & Zwinderman, A.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2010-03
Volume
9
Issue
3
Pages
254-263
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2165250822
Cited by
241
References
3
FWCI
3.57
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Netherlands Organization for Health Research and Development (NWO-Veni grant 2006 [916.76.023])
  • Academic Medical Center (AMC Fellowship 2008)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. https://app.cochat.ai/papers/10.1016/s1474-4422(10)70023-5
The paper
van de Beek, D., Farrar, J. J., de Gans, J., Mai, N. T. H., Molyneux, E. M., Peltola, H., Peto, T. E., Roine, I., Scarborough, M., Schultsz, C., Thwaites, G. E., Tuan, P. Q., & Zwinderman, A. (2010). Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(10)70023-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.